OPKO Health (OPK)
(Real Time Quote from BATS)
$1.56 USD
-0.07 (-4.29%)
Updated Dec 11, 2023 10:44 AM ET
3-Hold of 5 3
C Value B Growth F Momentum D VGM
OPKO Health (OPK) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$3.60 | $5.00 | $2.00 | 120.86% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for OPKO Health comes to $3.60. The forecasts range from a low of $2.00 to a high of $5.00. The average price target represents an increase of 120.86% from the last closing price of $1.63.
Analyst Price Targets (5 )
Broker Rating
OPKO Health currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, five are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown

Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
11/8/2023 | H.C. Wainwright & Co. | Yi Chen | Strong Buy | Strong Buy |
11/7/2023 | Barrington Research | Michael J Petusky | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 5 |
Average Target Price | $3.60 |
LT Growth Rate | NA |
Industry | Medical - Instruments |
Industry Rank by ABR | 83 of 252 |
Current Quarter EPS Est: | -0.09 |